How Editing RNA—Not DNA—Could Cure Disease in the Future
By Kristen V. Brown,
Gizmodo
| 03. 15. 2018
DNA is the code of life, and so advances that allow us to edit that code have unlocked vast potential, from simply editing away the buggy code of disease, to engineering animals that don’t spread illness, to, maybe one day in a distant future, creating so-called designer babies. But editing another essential molecular component of our biology—RNA, the messenger used by cells to turns DNA instructions into proteins—also holds great promise.
A slew of recent high-profile discoveries have focused on pairing the buzzy genetic engineering tool, CRISPR, with RNA editing. RNA is a sort of middleman that turns genetic instructions from DNA into proteins. Editing RNA could allow scientists to tweak how genes are expressed without making permanent changes to the genome itself—thus avoiding one of the scarier aspects of genetic engineering, because you’d be interfering with DNA’s instructions rather than editing DNA itself. RNA is ephemeral, which means changes to it could be reversed. And in some diseases, like a form of muscular dystrophy called myotonic dystrophy, mutant RNA is actually the root of the problem.
In October...
Related Articles
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Philip Ball , Nature | 06.17.2026
Our genomes are full of mutations that have the potential to damage our health or even kill us. Yet most of them rarely cause problems. Why? It’s partly thanks to a family of proteins that mask, or ‘buffer’, the ill...
By Philip Ball, Quanta Magazine | 06.18.2026
Since its molecular structure was deduced in the 1950s, DNA has been hailed by many biologists as the secret of life. They’ve read and studied the information stored in the DNA found in the cells of living organisms, known as...
By Arche Noah, GMWatch | 06.17.2026
The European Parliament has voted for a wide-reaching deregulation of New Genomic Techniques (NGTs). There was no majority for amendments stopping patents on conventionally classically bred plants or NGT plants. “Today’s vote is a missed opportunity to protect Europe’s farmers...